Tumour heterogeneity and cancer cell plasticity

2013/09/17 by Corbin E. Meacham, Sean J. Morrison · 47 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer Genomics and Diagnostics #Cancer Cells and Metastasis #Microtubule and mitosis dynamics

paper · doi:10.1038/nature12624

Cited by

• Polymer-lipid hybrid nanovesicle-enabled combination of immunogenic chemotherapy and RNAi-mediated PD-L1 knockdown elicits antitumor immunity against melanoma
• Evolutionary Dynamics of Acid Resistance in Tumors: A Mathematical Model
• Stemness regulation in prostate cancer: prostate cancer stem cells and targeted therapy
• Cancer-on-a-chip for precision cancer medicine
• Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
• An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network
• The present and future of the Cancer Dependency Map
• A hormetic transcriptional program coregulates invasion, proliferation and dormancy to define metastatic potential
• Advances in Single-Cell Techniques for Linking Phenotypes to Genotypes
• Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistance
• The multilayered transcriptional architecture of glioblastoma ecosystems
• LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1 -Mutant Lung Cancer
• Cancer cell plasticity: Impact on tumor progression and therapy response
• Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
• Likelihood-Based Heterogeneity Inference Reveals Non-Stationary Effects in Biohybrid Cell-Cargo Transport
• Matrix stiffness-sensitive long noncoding RNA NEAT1 seeded paraspeckles in cancer cells
• Distance-Correlation based Gene Set Analysis in Longitudinal Studies
• Prostate Cancer Development, Progression, and Therapy
• Cancer Evolution: Mathematical Models and Computational Inference
• Induction of a metabolic switch from glucose to ketone metabolism programs ketogenic diet-induced therapeutic vulnerability in lung cancer
• A Dirichlet Process Mixture Model for Clustering Longitudinal Gene Expression Data
• Bayesian Landmark-based Shape Analysis of Tumor Pathology Images
• Metastatic stem cells: sources, niches, and vital pathways. [europepmc]
• Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. [europepmc]
• Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. [europepmc]
• The MAPK pathway across different malignancies: a new perspective. [europepmc]
• Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. [europepmc]
• TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma. [europepmc]
• The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? [europepmc]
• EMT and tumor metastasis. [europepmc]
• Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence. [europepmc]
• High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. [europepmc]
• Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. [europepmc]
• Intra-tumor heterogeneity from a cancer stem cell perspective. [europepmc]
• Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism. [europepmc]
• In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers. [europepmc]
• Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer. [europepmc]
• Towards personalized, tumour-specific, therapeutic vaccines for cancer. [europepmc]
• Progress and challenges towards targeted delivery of cancer therapeutics. [europepmc]
• Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. [europepmc]
• Genetics and biology of prostate cancer. [europepmc]
• Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. [europepmc]
• CancerSEA: a cancer single-cell state atlas. [europepmc]
• Cellular Plasticity in Cancer. [europepmc]
• Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment. [europepmc]
• Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy. [europepmc]
• Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets. [europepmc]